# Hemodynamic Phenotype-Based,Capillary Refill Time-Targeted Resuscitation In Early Septic Shock:ANDROMEDA-SHOCK-2

> **NCT06062303** · NA · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 180 (estimated)

## Conditions studied

- Intensive Care Unit Acquired Weakness
- Shock, Septic

## Interventions

- **OTHER:** Usual care (UC)

## Key facts

- **NCT ID:** NCT06062303
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-06
- **Primary completion:** 2025-12-01
- **Final completion:** 2026-05-30
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2024-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06062303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06062303, "Hemodynamic Phenotype-Based,Capillary Refill Time-Targeted Resuscitation In Early Septic Shock:ANDROMEDA-SHOCK-2". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06062303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*